Insulet CFO to step down to join 3M's healthcare business

📆 19/03/45 03:15 ص
📰 YahooFinanceCA

⏱ Reading Time:
29 sec. here
2 min. at publisher
📊 Quality Score:
News: 15%
Publisher: 63%

المملكة العربية السعودية أخبار أخبار

المملكة العربية السعودية أحدث الأخبار,المملكة العربية السعودية عناوين

McMillan would join 3M as the financial chief of its healthcare business, which the U.S. industrial conglomerate plans to spin off into a listed company. 3M expects to complete the planned spinoff, which it disclosed last year, by the end of 2023.

- Insulet Corp said on Tuesday Wayde McMillan would step down as the medical device maker's chief financial officer, effective Oct. 20, to join 3M's healthcare business.

The company expects full-year revenue growth of 22% to 25%, compared with its previous forecast of 18% to 22% growth. It sees total sales growth of its insulin delivery devices, Omnipod, to be at 25% to 28%, compared with its previous projection of 21% to 25% rise.I wouldn’t be surprised if ENB stock even doubles in value in the next 10 years. Here why. The post Where Will Enbridge Stock Be in 10 Years? appeared first on The Motley Fool Canada.

Billionaire investor Bill Ackman says he would be 'absolutely' interested in a deal with Elon Musk's X

اكتب تعليق

لقد قمنا بتلخيص هذا الخبر حتى تتمكن من قراءته بسرعة. إذا كنت مهتمًا بالأخبار، يمكنك قراءة النص الكامل هنا. اقرأ أكثر:

المملكة العربية السعودية أحدث الأخبار, المملكة العربية السعودية عناوين